Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › WI › MADISON › UNIVERSITY OF WISCONSIN HOSPITALS AND CLINICS AUTHORITY

UNIVERSITY OF WISCONSIN HOSPITALS AND CLINICS AUTHORITY

NPI: 1922043744 · MADISON, WI 53792 · General Acute Care Hospital · NPI assigned 06/17/2006

$120.16M
Total Medicaid Paid
4,116,346
Total Claims
3,268,901
Beneficiaries
963
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialKAPLAN, ALAN (CEO)
NPI Enumeration Date06/17/2006

Related Entities

Other providers sharing the same authorized official: KAPLAN, ALAN

ProviderCityStateTotal Paid
UNIVERSITY OF WISCONSIN HOSPITALS AND CLINICS AUTHORITY MIDDLETON WI $883K
UNIVERSITY OF WISCONSIN HOSPITALS AND CLINICS AUTHORITY MADISON WI $27K
UNIVERSITY OF WISCONSIN HOSPITALS AND CLINICS AUTHORITY MADISON WI $2K
UNIVERSITY OF WISCONSIN HOSPITALS AND CLINICS AUTHORITY MADISON WI $1K
UNIVERSITY OF WISCONSIN HOSPITALS AND CLINICS AUTHORITY MADISON WI $1K
UNIVERSITY OF WISCONSIN HOSPITALS AND CLINICS AUTHORITY MADISON WI $824.85
UNIVERSITY OF WISCONSIN HOSPITALS AND CLINICS AUTHORITY MADISON WI $348.90
UNIVERSITY OF WISCONSIN HOSPITALS AND CLINICS AUTHORITY MADISON WI $17.88

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 448,732 $13.48M
2019 478,750 $15.23M
2020 441,614 $13.20M
2021 624,384 $16.77M
2022 653,431 $16.86M
2023 781,182 $23.47M
2024 688,253 $21.15M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 273,073 218,838 $18.10M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 84,559 66,963 $7.28M
T2023 Targeted case management; per month 16,284 16,153 $6.79M
96361 Intravenous infusion, hydration; each additional hour 42,385 29,542 $4.93M
99283 Emergency department visit for the evaluation and management, moderate severity 45,827 40,620 $2.71M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 42,603 37,790 $2.70M
99284 Emergency department visit for the evaluation and management, high severity 46,442 41,408 $2.65M
A0431 Ambulance service, conventional air services, transport, one way (rotary wing) 1,743 1,256 $2.54M
80053 Comprehensive metabolic panel 79,593 63,979 $2.48M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 34,233 20,996 $2.46M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 34,034 29,750 $1.79M
Q3014 Telehealth originating site facility fee 44,704 37,014 $1.67M
80048 Basic metabolic panel (calcium, ionized) 61,317 49,035 $1.58M
99215 Prolong outpt/office vis 15,097 12,611 $1.37M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 19,409 18,308 $1.29M
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 10,860 10,207 $1.18M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 5,415 5,036 $1.02M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 11,797 10,236 $1.01M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 10,477 9,391 $1.00M
74177 Computed tomography, abdomen and pelvis; with contrast material 14,942 13,476 $986K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 49,094 29,908 $978K
A0436 Rotary wing air mileage, per statute mile 1,733 1,250 $975K
77386 7,997 764 $970K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 121,685 96,343 $833K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 9,054 6,195 $811K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 102,383 78,916 $790K
64643 5,001 3,480 $777K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 6,384 5,978 $739K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 18,656 17,118 $735K
P9016 Red blood cells, leukocytes reduced, each unit 1,113 910 $718K
70450 Computed tomography, head or brain; without contrast material 11,692 10,318 $706K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 10,854 5,982 $701K
81001 60,484 50,284 $699K
J0588 Injection, incobotulinumtoxin a, 1 unit 6,223 5,940 $595K
45380 Colonoscopy, flexible; with biopsy, single or multiple 3,745 3,478 $587K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 14,699 12,858 $578K
97530 Therapeutic activities, direct patient contact, each 15 minutes 13,661 9,265 $573K
99281 Emergency department visit for the evaluation and management, self-limited or minor 8,966 8,160 $562K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 6,803 6,252 $547K
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg 1,349 839 $540K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 43,003 38,573 $536K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 12,298 10,042 $496K
99282 Emergency department visit for the evaluation and management, low to moderate severity 9,187 8,286 $486K
76770 5,385 5,116 $472K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 18,836 7,502 $463K
87631 4,906 4,399 $444K
42820 Tonsillectomy and adenoidectomy; younger than age 12 925 877 $429K
64642 3,345 3,185 $427K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study 2,213 2,073 $410K
80061 Lipid panel 16,422 15,090 $397K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 15,097 12,883 $372K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 2,089 1,947 $372K
80197 12,506 7,965 $370K
83036 Hemoglobin; glycosylated (A1C) 22,537 20,514 $366K
96040 2,782 2,579 $348K
70551 Magnetic resonance imaging, brain; without contrast material 3,424 3,100 $343K
93321 3,032 2,821 $337K
41899 Unlisted procedure, dentoalveolar structures 880 816 $337K
71275 Computed tomographic angiography, chest, with contrast material 4,584 4,162 $330K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 1,013 947 $326K
97162 9,656 8,843 $321K
92567 7,467 7,020 $317K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 8,932 5,469 $310K
96367 4,655 3,464 $310K
96138 2,256 1,900 $291K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 11,202 7,349 $290K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 4,890 4,374 $281K
84443 Thyroid stimulating hormone (TSH) 24,441 22,050 $279K
J0475 Injection, baclofen, 10 mg 2,572 2,450 $277K
76705 Ultrasound, abdominal, real time with image documentation; limited 8,128 7,412 $277K
93320 2,221 2,061 $271K
G0378 Hospital observation service, per hour 14,491 7,336 $265K
92523 2,825 2,603 $261K
J0585 Injection, onabotulinumtoxina, 1 unit 3,432 3,148 $258K
93308 1,708 1,602 $256K
82728 15,459 14,082 $255K
80051 10,415 8,408 $249K
96139 2,244 1,848 $240K
82565 24,291 19,548 $232K
93325 5,585 5,135 $230K
87081 5,550 4,848 $229K
96415 2,260 1,485 $228K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 4,088 3,683 $228K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 4,264 4,084 $227K
C9257 Injection, bevacizumab, 0.25 mg 1,885 1,710 $225K
82962 34,931 18,144 $223K
87086 Culture, bacterial; quantitative colony count, urine 18,976 16,305 $223K
74183 2,550 2,286 $223K
52000 946 902 $222K
84484 34,068 23,553 $221K
93356 2,329 2,141 $220K
77336 4,010 1,865 $217K
82247 14,061 11,279 $214K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 14,300 8,247 $212K
G0175 Scheduled interdisciplinary team conference (minimum of three exclusive of patient care nursing staff) with patient present 4,590 4,310 $211K
87077 14,806 10,293 $204K
62370 1,551 1,492 $202K
76497 9,611 8,654 $197K
20553 2,993 2,795 $196K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1,481 1,379 $195K
87070 7,270 5,342 $195K
84702 11,986 10,345 $194K
74176 Computed tomography, abdomen and pelvis; without contrast material 3,528 3,156 $193K
74230 2,127 1,973 $191K
81025 18,525 16,386 $191K
64615 2,850 2,648 $191K
20610 3,587 3,088 $190K
85027 34,436 26,679 $189K
36430 1,867 1,244 $189K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 4,555 4,094 $188K
83880 8,811 7,707 $184K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2,935 2,840 $182K
86832 3,569 3,124 $170K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 2,693 2,329 $167K
49083 1,013 425 $167K
90837 Psychotherapy, 53 minutes with patient 2,912 1,763 $165K
95816 1,411 1,336 $165K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 8,505 7,635 $164K
92609 3,796 2,423 $162K
83735 40,382 30,661 $161K
31575 2,261 2,057 $158K
95874 3,968 3,784 $158K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 814 757 $157K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 6,425 5,627 $153K
72141 2,435 2,216 $152K
83970 7,457 5,899 $152K
96130 1,158 915 $151K
96417 2,956 1,691 $148K
72197 1,507 1,317 $147K
49452 730 684 $146K
71260 Computed tomography, thorax, diagnostic; with contrast material 2,604 2,317 $146K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 2,101 2,035 $144K
83605 22,530 16,080 $143K
86833 3,598 3,148 $141K
93304 702 648 $140K
84439 9,466 8,499 $139K
20611 1,385 1,257 $137K
64644 1,838 1,756 $136K
86850 16,195 14,072 $133K
97166 3,882 3,521 $133K
71250 5,562 5,003 $130K
87507 404 371 $130K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 5,655 5,136 $129K
70546 1,377 1,294 $127K
70496 1,678 1,516 $125K
85610 25,430 20,650 $125K
97161 4,556 4,058 $124K
87536 2,238 1,946 $123K
J2357 Injection, omalizumab, 5 mg 591 453 $122K
72125 Computed tomography, cervical spine; without contrast material 4,948 4,445 $117K
43235 638 606 $115K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography 1,927 1,730 $114K
92579 2,178 2,068 $112K
52310 465 420 $109K
17250 860 762 $109K
82784 10,211 5,144 $109K
67028 Intravitreal injection of a pharmacologic agent 2,967 2,695 $108K
82803 6,672 5,079 $107K
82040 6,457 5,474 $106K
93017 2,863 2,595 $106K
86780 6,272 5,632 $105K
70498 1,475 1,344 $104K
16020 2,048 1,272 $104K
70491 1,653 1,492 $104K
83690 25,894 21,834 $104K
94010 7,960 7,115 $102K
72158 1,168 1,056 $101K
77412 888 129 $101K
99205 Prolong outpt/office vis 1,265 1,160 $100K
93296 4,470 4,297 $98K
92526 2,374 1,800 $97K
86803 7,978 7,066 $96K
97116 5,104 3,114 $96K
86480 2,046 1,807 $95K
82805 4,191 3,438 $95K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 434 355 $95K
87653 1,188 1,131 $94K
93971 3,649 3,296 $92K
76830 Ultrasound, transvaginal 3,395 3,112 $92K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,846 1,436 $90K
87102 6,627 5,746 $88K
92610 1,642 1,522 $88K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 23,097 14,984 $88K
84466 10,979 10,125 $88K
95886 1,807 1,671 $85K
95700 685 645 $84K
95819 791 752 $84K
87497 3,336 2,245 $83K
87799 5,408 3,436 $83K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2,034 1,748 $83K
72156 917 816 $81K
90686 10,055 9,402 $81K
92611 1,372 1,274 $81K
82105 3,519 3,111 $81K
90834 Psychotherapy, 45 minutes with patient 1,179 863 $80K
62369 826 784 $80K
76536 2,017 1,859 $80K
87641 3,706 3,128 $79K
83655 2,700 2,570 $78K
96131 768 595 $78K
97165 2,574 2,286 $77K
77301 411 364 $75K
87640 2,726 2,501 $75K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1,878 1,199 $73K
82607 5,911 5,363 $72K
29405 754 536 $71K
88305 Level IV - Surgical pathology, gross and microscopic examination 28,766 19,133 $71K
96156 1,220 1,081 $71K
97113 2,958 1,340 $70K
29075 969 830 $69K
84450 17,815 15,054 $69K
80050 General health panel 5,704 5,222 $69K
93975 1,418 1,323 $69K
43762 1,515 1,399 $68K
12001 1,063 1,001 $68K
80069 2,422 2,123 $68K
82570 15,296 12,567 $68K
87522 Neg quan hep c or qual rna 2,232 1,956 $67K
82077 7,897 6,701 $67K
77300 1,496 1,156 $67K
84460 20,647 17,374 $66K
96136 854 678 $66K
91322 1,031 977 $66K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 1,204 1,067 $64K
96137 811 634 $64K
94060 2,375 2,205 $63K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 4,790 4,452 $63K
86003 8,868 1,104 $61K
97163 2,286 2,109 $61K
76857 3,535 3,242 $60K
93798 983 657 $60K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 58,662 47,329 $60K
92524 1,508 1,391 $59K
70486 1,623 1,462 $59K
95716 420 333 $58K
84145 4,211 3,775 $58K
96101 317 187 $57K
92557 1,899 1,772 $57K
94660 1,678 941 $57K
80164 1,231 1,075 $56K
81003 3,061 2,575 $56K
70544 859 781 $56K
86359 2,172 1,863 $55K
J0178 Injection, aflibercept, 1 mg 383 348 $55K
64616 476 447 $55K
82310 4,995 4,160 $54K
51784 1,024 958 $54K
87340 6,873 6,035 $54K
64400 579 438 $54K
72157 617 542 $54K
82043 4,620 4,126 $54K
96368 797 623 $52K
83540 11,162 10,282 $52K
80143 4,399 3,768 $52K
86140 16,224 13,678 $52K
86762 1,834 1,672 $52K
92083 2,517 2,355 $52K
31622 213 191 $52K
92582 1,622 1,548 $52K
71046 Radiologic examination, chest; 2 views 22,416 19,713 $51K
76499 1,340 1,246 $51K
86704 4,404 3,821 $51K
90670 2,674 2,563 $51K
76882 1,577 1,383 $51K
97535 Self-care/home management training, each 15 minutes 3,596 2,435 $51K
76642 1,880 1,694 $51K
77002 2,224 1,868 $51K
77334 1,272 922 $50K
72146 854 788 $49K
87186 10,252 7,708 $49K
86360 1,614 1,403 $48K
86900 15,522 13,152 $48K
73221 891 782 $48K
82947 12,121 9,692 $48K
77067 Screening mammography, bilateral, including computer-aided detection 2,075 1,951 $47K
74018 4,552 3,794 $47K
95117 1,683 925 $47K
77080 830 781 $47K
84100 16,481 12,117 $46K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 180 174 $46K
87015 2,572 1,463 $46K
86706 5,241 4,569 $46K
82977 9,212 7,531 $46K
72082 2,636 2,508 $45K
92552 1,055 978 $44K
96119 255 203 $44K
92607 769 727 $43K
64450 785 662 $43K
95885 950 789 $43K
11102 522 484 $42K
87506 318 288 $42K
92555 1,147 1,098 $41K
96110 Developmental screening, with scoring and documentation, per standardized instrument 177 170 $41K
72128 1,732 1,545 $41K
96111 179 138 $41K
86923 3,482 1,901 $41K
87205 13,619 10,787 $41K
50200 390 357 $40K
90651 1,394 1,342 $40K
96152 1,185 825 $40K
92504 2,498 2,291 $40K
87040 5,645 2,966 $40K
85379 6,513 5,887 $39K
80179 4,251 3,662 $39K
94618 2,362 2,060 $38K
12011 628 587 $38K
96150 567 478 $38K
82550 5,603 4,635 $38K
64405 461 417 $37K
29581 353 78 $37K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 680 645 $37K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 36,310 30,282 $36K
85652 13,978 11,850 $36K
93976 1,260 1,133 $35K
J9271 Injection, pembrolizumab, 1 mg 31 26 $35K
93797 824 205 $35K
96116 259 194 $34K
82950 839 793 $34K
87493 1,125 893 $34K
82533 2,367 1,893 $34K
82670 902 805 $33K
84075 11,393 9,408 $33K
84403 1,683 1,494 $33K
92134 7,581 6,909 $32K
93225 2,136 2,019 $31K
82140 2,170 1,846 $31K
85730 8,434 7,379 $31K
64447 296 263 $31K
84156 11,087 9,104 $30K
J9299 Injection, nivolumab, 1 mg 33 26 $30K
82746 3,536 3,200 $29K
76870 1,010 919 $29K
86901 15,523 13,153 $29K
84132 6,595 4,888 $28K
90677 1,541 1,427 $28K
90680 1,965 1,910 $28K
81229 60 55 $28K
51705 922 794 $28K
77338 436 384 $28K
86038 3,073 2,718 $28K
86235 914 606 $28K
95951 170 131 $28K
86160 3,055 1,475 $28K
17110 583 521 $27K
90734 1,526 1,452 $27K
77063 Screening digital breast tomosynthesis, bilateral 1,573 1,477 $27K
31579 234 208 $27K
83615 7,100 5,498 $26K
97167 671 623 $26K
82150 3,251 2,528 $26K
90911 249 152 $26K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 1,727 1,577 $26K
51741 735 675 $24K
83520 1,301 1,083 $24K
83021 893 766 $24K
83516 1,835 1,475 $24K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 11,608 10,625 $24K
82330 2,488 2,048 $23K
85048 3,434 2,553 $23K
G0008 Administration of influenza virus vaccine 5,807 5,313 $23K
94003 92 57 $23K
72131 849 772 $22K
71555 165 156 $22K
84295 1,683 1,339 $21K
52356 31 29 $21K
87206 6,362 4,469 $20K
97602 1,454 1,226 $20K
81000 1,342 1,116 $20K
84520 10,063 8,279 $20K
84153 1,560 1,361 $20K
84481 1,556 1,386 $19K
76881 663 551 $19K
88307 3,042 2,154 $19K
64415 113 96 $19K
76942 5,213 4,755 $19K
93970 513 478 $19K
85018 7,902 6,413 $19K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 248 226 $19K
93226 2,137 2,012 $19K
97597 509 357 $19K
10060 352 315 $19K
87529 444 375 $18K
90791 Psychiatric diagnostic evaluation 1,111 800 $18K
92522 400 375 $18K
43760 263 233 $18K
82525 1,078 1,008 $18K
70543 147 132 $18K
85014 5,960 4,732 $18K
90716 605 582 $18K
88342 7,039 5,539 $18K
86708 2,123 1,812 $18K
72170 4,877 4,455 $17K
86769 608 560 $17K
81329 160 155 $17K
88341 3,517 2,016 $17K
85049 1,477 1,292 $17K
90647 2,276 2,205 $17K
83993 523 477 $16K
84146 807 705 $16K
96376 15,564 10,339 $16K
73130 4,340 3,448 $16K
77066 Tomosynthesis, mammo 886 840 $16K
82465 769 682 $16K
P9047 Infusion, albumin (human), 25%, 50 ml 158 65 $16K
J1745 Injection, infliximab, excludes biosimilar, 10 mg 41 36 $15K
84630 1,539 1,462 $15K
0001A 1,561 1,427 $15K
64483 111 105 $15K
73630 5,385 4,457 $15K
J0741 Injection, cabotegravir and rilpivirine, 2mg/3mg 13 13 $15K
0002A 1,401 1,309 $15K
84550 4,200 3,529 $15K
76937 1,310 1,094 $15K
90715 2,829 2,668 $15K
31624 57 40 $15K
87075 2,766 1,548 $14K
86356 528 402 $14K
73610 5,087 4,081 $14K
94726 2,272 2,066 $14K
86364 1,756 1,628 $14K
69210 663 627 $14K
36415 Collection of venous blood by venipuncture 118,055 80,036 $14K
86355 557 477 $14K
89051 2,797 1,703 $14K
83001 733 670 $14K
90480 1,019 987 $14K
73502 3,563 3,157 $14K
84305 535 505 $14K
74174 198 186 $14K
86592 1,523 1,298 $13K
96450 104 91 $13K
20552 201 188 $13K
86255 1,330 760 $13K
92133 2,477 2,311 $13K
95911 324 292 $13K
73090 2,386 1,750 $13K
71045 Radiologic examination, chest; single view 14,731 12,701 $12K
73030 4,699 3,935 $12K
82785 561 508 $12K
90633 1,633 1,562 $12K
94729 3,497 3,217 $12K
80175 395 347 $12K
96375 Therapeutic injection; each additional sequential IV push 31,031 23,067 $12K
77062 503 487 $12K
73560 3,729 3,092 $12K
20550 159 127 $12K
J1453 Injection, fosaprepitant, 1 mg 609 401 $12K
92250 3,137 2,883 $12K
51702 895 752 $11K
97760 813 721 $11K
73110 4,061 3,217 $11K
97763 683 548 $11K
94799 10,453 5,891 $11K
96402 533 460 $11K
75561 88 79 $11K
96158 349 261 $11K
93922 570 537 $10K
87517 456 405 $10K
83521 692 578 $10K
85046 2,322 1,804 $10K
82103 726 631 $10K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 225 218 $10K
84155 3,981 3,315 $10K
77295 55 40 $10K
87184 2,203 1,630 $10K
86225 1,107 974 $10K
73590 3,535 2,776 $10K
84165 1,889 1,593 $9K
38222 65 52 $9K
80177 562 509 $9K
0202U Oncology (prostate), multianalyte, gene expression profiling 578 524 $9K
82024 147 135 $9K
87902 52 43 $9K
95930 56 55 $9K
83525 678 632 $9K
92587 360 342 $9K
67311 12 12 $9K
80375 519 465 $9K
80178 339 266 $9K
73700 254 203 $9K
51798 4,121 3,700 $9K
42830 20 19 $9K
72040 2,245 2,022 $9K
90656 1,066 1,042 $8K
72100 2,894 2,637 $8K
83992 520 466 $8K
90723 2,265 2,203 $8K
G0379 Direct admission of patient for hospital observation care 337 294 $8K
96132 58 50 $8K
11900 158 150 $8K
94664 930 857 $8K
82378 490 427 $8K
96120 87 69 $8K
36561 26 24 $8K
86334 800 669 $8K
88304 2,503 2,046 $8K
43249 42 36 $8K
85045 2,743 2,247 $8K
88185 1,475 831 $8K
73140 2,027 1,699 $8K
86618 545 485 $8K
84425 588 531 $8K
31231 331 309 $7K
80324 518 464 $7K
86644 744 609 $7K
82248 1,799 1,466 $7K
92556 584 538 $7K
73552 2,072 1,704 $7K
88184 1,043 871 $7K
17311 46 37 $7K
82010 955 707 $7K
86787 1,098 904 $7K
82390 731 641 $7K
73080 2,020 1,724 $7K
76981 421 406 $7K
73564 1,769 1,447 $7K
96164 159 87 $7K
77065 Tomosynthesis, mammo 540 466 $7K
88142 409 362 $7K
77073 979 924 $6K
92608 227 219 $6K
85007 1,500 1,057 $6K
95910 186 176 $6K
11104 56 53 $6K
83002 414 374 $6K
86765 650 571 $6K
86200 589 532 $6K
75574 73 56 $6K
73562 3,183 2,743 $6K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 35,950 31,412 $6K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 82 67 $5K
31720 363 291 $5K
88313 3,544 2,177 $5K
94762 67 53 $5K
J0185 Injection, aprepitant, 1 mg 177 116 $5K
0004A 834 710 $5K
J9217 Leuprolide acetate (for depot suspension), 7.5 mg 74 66 $5K
88312 1,636 1,005 $5K
87625 210 187 $5K
73100 1,245 924 $5K
90620 179 177 $5K
86735 564 497 $5K
86665 414 259 $5K
96416 38 26 $5K
77091 692 645 $5K
81002 269 241 $5K
J1611 Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg 172 152 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 319 292 $4K
12002 74 68 $4K
84255 212 210 $4K
78264 36 36 $4K
99152 5,006 4,517 $4K
80076 113 103 $4K
90707 817 787 $4K
82610 297 277 $4K
95812 32 30 $4K
88112 1,431 1,258 $4K
Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg 25 12 $4K
87338 96 95 $4K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 264 245 $4K
73070 1,384 988 $4K
11100 70 68 $4K
J1170 Injection, hydromorphone, up to 4 mg 32,056 20,525 $4K
84446 308 293 $3K
74220 137 129 $3K
77061 126 113 $3K
91200 340 316 $3K
J3010 Injection, fentanyl citrate, 0.1 mg 36,342 30,967 $3K
51600 89 80 $3K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 2,793 2,508 $3K
77280 62 40 $3K
94761 6,303 5,562 $3K
82104 300 262 $3K
0124A 262 252 $3K
74240 32 27 $3K
90696 409 394 $3K
90732 707 637 $3K
90832 Psychotherapy, 30 minutes with patient 54 39 $3K
90685 102 98 $3K
90714 463 422 $3K
90847 Family psychotherapy with the patient present, 50 minutes 50 27 $3K
96153 576 241 $3K
90846 Family psychotherapy without the patient present, 50 minutes 38 25 $3K
90381 20 19 $3K
86015 371 342 $3K
97750 259 226 $3K
84590 313 300 $3K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 3,679 3,167 $3K
62323 13 12 $2K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 633 562 $2K
0054A 237 233 $2K
82951 38 38 $2K
77072 233 226 $2K
77081 343 323 $2K
70487 28 26 $2K
29065 31 26 $2K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 15 12 $2K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 105 99 $2K
82945 135 108 $2K
92136 493 452 $2K
83921 153 141 $2K
89050 262 200 $2K
P9045 Infusion, albumin (human), 5%, 250 ml 50 27 $2K
95974 12 12 $2K
92553 30 28 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg 29,437 25,600 $2K
G0659 Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes 40 40 $2K
0071A 327 242 $2K
72198 12 12 $2K
86308 350 324 $2K
G0249 Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests 214 205 $2K
J1610 Injection, glucagon hydrochloride, per 1 mg 69 66 $2K
88172 577 272 $2K
84402 102 89 $2K
74019 889 809 $2K
93246 136 123 $2K
86376 205 190 $2K
84207 113 109 $2K
76885 25 25 $2K
82379 108 104 $2K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 7,579 6,606 $2K
82397 81 81 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 73 65 $2K
85576 141 56 $2K
90700 546 525 $2K
90691 264 245 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg 29,583 23,748 $2K
90710 518 483 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 46,806 37,939 $2K
88360 497 248 $2K
85246 96 85 $2K
83718 471 423 $2K
85245 94 84 $2K
85520 135 119 $2K
76700 Ultrasound, abdominal, real time with image documentation; complete 12 12 $2K
73060 699 563 $2K
77085 189 170 $2K
0072A 236 210 $2K
92551 55 55 $2K
86304 93 77 $2K
81015 111 106 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 39 39 $2K
51728 39 37 $2K
82627 58 54 $2K
96409 1,058 670 $1K
C8928 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report 30 28 $1K
82340 189 159 $1K
86381 141 134 $1K
87634 14 13 $1K
86431 409 384 $1K
80305 49 43 $1K
74420 30 27 $1K
97802 193 182 $1K
J1050 Injection, medroxyprogesterone acetate, 1 mg 1,052 1,008 $1K
99153 Mod sedat endo service >5yrs 4,344 3,807 $1K
62270 12 12 $1K
80195 41 25 $1K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 32 15 $1K
93298 122 120 $1K
M0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring 26 24 $1K
90472 Immunization administration, each additional vaccine (list separately) 3,777 2,983 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 23,461 19,416 $1K
96401 228 88 $1K
90739 216 197 $1K
70549 12 12 $1K
51726 14 12 $1K
78306 12 12 $1K
J7050 Infusion, normal saline solution, 250 cc 35,229 14,319 $1K
87071 32 27 $1K
97803 288 279 $1K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results 59 55 $1K
92591 15 13 $1K
C1776 Joint device (implantable) 364 306 $1K
J2704 Injection, propofol, 10 mg 26,220 20,819 $1K
84134 333 300 $993.27
99070 113 109 $970.73
C1760 Closure device, vascular (implantable/insertable) 1,353 1,184 $960.72
82657 15 12 $950.19
J7120 Ringers lactate infusion, up to 1000 cc 9,403 7,306 $936.25
J1756 Injection, iron sucrose, 1 mg 316 182 $935.13
92652 13 12 $926.49
A9577 Injection, gadobenate dimeglumine (multihance), per ml 15,509 13,608 $922.68
C1769 Guide wire 3,777 3,092 $921.94
87088 127 110 $917.65
84681 247 229 $906.65
76512 44 39 $904.72
82542 16 15 $895.79
83090 56 50 $866.97
85347 380 114 $839.82
90717 33 33 $825.76
90694 440 382 $811.07
84157 198 162 $802.60
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 16 15 $799.14
97810 233 122 $779.56
80183 25 24 $772.98
90662 405 372 $768.04
Q9957 Injection, perflutren lipid microspheres, per ml 1,902 1,675 $763.58
93299 12 12 $750.87
36416 1,220 1,062 $746.12
80346 519 465 $735.09
0121A 71 61 $732.08
J0690 Injection, cefazolin sodium, 500 mg 9,838 7,684 $728.33
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3,597 3,052 $724.84
83498 29 27 $706.50
91300 169 140 $697.99
J2060 Injection, lorazepam, 2 mg 3,728 3,086 $678.54
73600 1,112 951 $674.09
84300 316 264 $667.86
C1726 Catheter, balloon dilatation, non-vascular 731 644 $656.74
92520 13 13 $648.34
74455 14 12 $647.46
95912 12 12 $643.79
70250 48 45 $642.68
86036 92 84 $640.55
97164 13 12 $639.91
92025 327 310 $625.87
98960 411 388 $624.55
17000 28 24 $617.47
95713 12 12 $603.35
91321 236 230 $602.59
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 1,891 1,682 $598.82
82435 261 226 $597.73
85240 79 70 $590.70
88173 831 425 $589.26
86361 38 28 $583.23
J0696 Injection, ceftriaxone sodium, per 250 mg 7,088 5,469 $579.55
84432 29 26 $569.34
77090 122 112 $561.41
84270 28 28 $542.66
86800 49 47 $537.06
87449 93 52 $528.15
83876 40 38 $519.75
80364 790 714 $519.60
62368 31 27 $514.12
A9581 Injection, gadoxetate disodium, 1 ml 251 224 $497.49
J1200 Injection, diphenhydramine hcl, up to 50 mg 8,591 6,602 $493.74
84244 25 25 $484.92
87116 80 55 $474.33
80326 266 244 $454.74
A9573 Injection, gadopiclenol, 1 ml 2,809 2,605 $444.48
J2795 Injection, ropivacaine hydrochloride, 1 mg 3,787 3,332 $441.76
J1815 Injection, insulin, per 5 units 5,443 2,238 $441.74
J3480 Injection, potassium chloride, per 2 meq 2,933 2,099 $441.26
87385 79 53 $422.89
88237 14 12 $421.64
59025 Fetal non-stress test 22 12 $419.93
87427 29 25 $418.79
86709 47 43 $409.51
J2997 Injection, alteplase recombinant, 1 mg 27 25 $403.21
76825 15 13 $402.13
C1887 Catheter, guiding (may include infusion/perfusion capability) 2,406 2,067 $400.53
84478 35 27 $397.95
83010 58 38 $394.05
J0330 Injection, succinylcholine chloride, up to 20 mg 4,073 3,424 $392.61
80359 527 472 $387.81
J1644 Injection, heparin sodium, per 1000 units 5,919 3,049 $385.66
93280 24 24 $385.57
80372 520 466 $381.20
80356 520 466 $381.20
70355 15 13 $379.00
80358 520 466 $378.57
80373 520 466 $378.57
80353 520 466 $377.25
80348 520 466 $377.25
80354 520 466 $377.25
80360 520 466 $377.25
80361 520 466 $377.25
80365 520 466 $377.25
83883 71 38 $368.90
86301 38 37 $362.37
80176 70 59 $357.55
82239 27 27 $353.80
85613 42 40 $352.25
90672 20 19 $338.87
97035 51 27 $328.29
93880 14 13 $321.66
92060 122 115 $312.46
95991 16 12 $291.12
96411 613 392 $285.92
82652 12 12 $283.52
72070 273 237 $277.76
86039 35 31 $274.22
88331 152 127 $273.42
J1650 Injection, enoxaparin sodium, 10 mg 4,393 1,879 $271.85
97032 16 13 $270.25
G0380 Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) 69 50 $261.59
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 3,601 3,220 $261.21
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 22,627 12,118 $258.00
80347 267 245 $256.52
82374 91 79 $256.24
85732 42 40 $251.73
J7030 Infusion, normal saline solution , 1000 cc 11,847 7,932 $248.80
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 988 789 $245.47
J2785 Injection, regadenoson, 0.1 mg 220 197 $242.39
86705 34 26 $238.20
85250 16 13 $236.04
97811 190 90 $232.18
86147 18 13 $231.57
C1729 Catheter, drainage 462 406 $226.06
90653 103 99 $220.98
J0780 Injection, prochlorperazine, up to 10 mg 3,519 2,933 $220.12
76376 683 628 $216.65
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 8,732 4,204 $213.68
J1630 Injection, haloperidol, up to 5 mg 3,311 2,837 $204.46
J0131 Injection, acetaminophen, not otherwise specified,10 mg 2,412 2,064 $196.86
86357 13 12 $195.38
0003A 20 20 $194.96
20561 127 87 $194.70
76827 15 13 $191.48
0081A 24 23 $190.80
J9370 Vincristine sulfate, 1 mg 505 301 $187.53
J2270 Injection, morphine sulfate, up to 10 mg 3,045 2,305 $186.30
76391 15 13 $185.70
51797 42 40 $178.82
J0171 Injection, adrenalin, epinephrine, 0.1 mg 3,182 2,655 $177.63
88311 552 440 $175.55
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 11,325 6,948 $175.00
J3370 Injection, vancomycin hcl, 500 mg 3,935 2,819 $170.29
97542 13 12 $168.46
J2765 Injection, metoclopramide hcl, up to 10 mg 3,139 2,719 $160.74
82139 15 13 $160.32
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 2,573 1,678 $156.77
73000 395 331 $146.02
J0697 Injection, sterile cefuroxime sodium, per 750 mg 5,440 2,961 $142.10
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 3,297 2,797 $139.89
80355 267 245 $139.81
99188 881 835 $137.26
82232 28 12 $132.21
87350 14 13 $123.30
87176 37 24 $122.54
J3475 Injection, magnesium sulfate, per 500 mg 2,499 1,982 $118.67
J3411 Injection, thiamine hcl, 100 mg 1,762 1,375 $112.61
86707 13 12 $109.08
87106 12 12 $106.94
36591 64 40 $106.11
82952 26 26 $101.25
85384 46 13 $101.19
92201 277 267 $98.10
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 540 274 $93.55
0082A 13 13 $90.24
87045 29 25 $87.27
92511 37 37 $82.60
91312 547 510 $81.90
95970 41 40 $81.25
99459 32 26 $77.36
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 1,119 926 $76.74
95012 57 52 $73.87
96165 168 86 $71.83
82085 12 12 $71.09
83930 15 13 $70.14
83935 13 12 $65.19
87305 16 12 $61.90
91318 18 18 $55.56
85660 14 13 $51.38
86880 24 12 $50.13
86886 18 12 $50.00
77293 13 12 $47.00
51701 13 12 $45.52
J0613 Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg 45 25 $42.55
84540 34 24 $41.36
C9399 Unclassified drugs or biologicals 584 522 $40.32
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) 2,037 1,835 $39.11
0051A 12 12 $38.16
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 3,532 2,785 $35.96
A4648 Tissue marker, implantable, any type, each 994 918 $34.25
J8540 Dexamethasone, oral, 0.25 mg 5,727 1,974 $32.89
J2370 Injection, phenylephrine hcl, up to 1 ml 1,378 1,117 $32.76
A9575 Injection, gadoterate meglumine, 0.1 ml 379 318 $32.15
97150 Therapeutic procedure(s), group (2 or more individuals) 20 12 $31.90
87046 31 25 $28.39
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 3,836 2,176 $27.56
96159 121 84 $25.74
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 1,288 653 $25.43
77001 105 97 $23.04
95250 14 14 $22.92
90474 516 471 $22.40
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 306 278 $19.84
J7060 5% dextrose/water (500 ml = 1 unit) 5,427 2,384 $19.21
J1790 Injection, droperidol, up to 5 mg 840 728 $18.76
36592 16 15 $18.47
96381 31 30 $18.15
73660 15 14 $18.07
J2175 Injection, meperidine hydrochloride, per 100 mg 851 773 $16.74
J7042 5% dextrose/normal saline (500 ml = 1 unit) 1,627 1,227 $10.51
J1920 Injection, labetalol hydrochloride, 5 mg 491 380 $8.98
G0009 Administration of pneumococcal vaccine 124 116 $8.74
A4215 Needle, sterile, any size, each 572 477 $8.08
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 1,465 1,105 $6.32
J0360 Injection, hydralazine hcl, up to 20 mg 367 277 $5.95
J0461 Injection, atropine sulfate, 0.01 mg 87 54 $4.63
J2919 Injection, methylprednisolone sodium succinate, 5 mg 190 159 $4.23
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 224 188 $4.10
J1940 Injection, furosemide, up to 20 mg 482 304 $3.62
J0692 Injection, cefepime hydrochloride, 500 mg 427 223 $3.06
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 353 316 $2.60
J1836 Injection, metronidazole, 10 mg 223 148 $2.16
A6211 Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing 31 25 $1.78
J1953 Injection, levetiracetam, 10 mg 205 160 $1.58
J2003 Injection, lidocaine hydrochloride, 1 mg 779 558 $1.20
G0475 Hiv antigen/antibody, combination assay, screening 36 26 $1.15
J0670 Injection, mepivacaine hydrochloride, per 10 ml 85 80 $0.77
J1171 Injection, hydromorphone, 0.1 mg 627 368 $0.36
J1596 Injection, glycopyrrolate, 0.1 mg 235 201 $0.28
C2617 Stent, non-coronary, temporary, without delivery system 343 315 $0.00
J2560 Injection, phenobarbital sodium, up to 120 mg 164 128 $0.00
91317 18 18 $0.00
P9612 Catheterization for collection of specimen, single patient, all places of service 13 13 $0.00
G8981 Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals 61 56 $0.00
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg 69 50 $0.00
72020 62 52 $0.00
42975 74 71 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 210 188 $0.00
J9045 Injection, carboplatin, 50 mg 46 25 $0.00
G8998 Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting 42 39 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 43 41 $0.00
G8982 Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 65 59 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 34 28 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 44 42 $0.00
72190 13 12 $0.00
C2624 Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components 35 27 $0.00
72080 13 12 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 81 63 $0.00
J9250 Methotrexate sodium, 5 mg 53 24 $0.00
J1805 Injection, esmolol hydrochloride, 10 mg 32 28 $0.00
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 16 16 $0.00
J2305 Injection, nitroglycerin, 5 mg 67 61 $0.00
91315 55 53 $0.00
94668 27 13 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 17 15 $0.00
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 12 12 $0.00
A9300 Exercise equipment 25 24 $0.00
91307 13 12 $0.00
91305 12 12 $0.00
90461 235 226 $0.00
91308 103 101 $0.00
92202 61 54 $0.00
C1788 Port, indwelling (implantable) 26 24 $0.00
99177 728 703 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 643 566 $0.00
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries 260 239 $0.00
90460 Immunization administration through 18 years of age via any route, first or only component 392 373 $0.00
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 230 201 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 248 215 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 706 615 $0.00
95983 15 12 $0.00
G8996 Swallowing functional limitation, current status at therapy episode outset and at reporting intervals 42 39 $0.00
J2310 Injection, naloxone hydrochloride, per 1 mg 60 46 $0.00
J7510 Prednisolone oral, per 5 mg 33 25 $0.00
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg 81 69 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 99 89 $0.00
29105 12 12 $0.00
G8997 Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 42 39 $0.00
J1580 Injection, garamycin, gentamicin, up to 80 mg 59 39 $0.00
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg 13 13 $0.00
69209 13 12 $0.00
J9999 Not otherwise classified, antineoplastic drugs 64 26 $0.00
77387 92 12 $0.00
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 45 32 $0.00
A9999 Miscellaneous dme supply or accessory, not otherwise specified 32 27 $0.00
J3489 Injection, zoledronic acid, 1 mg 12 12 $0.00
77089 12 12 $0.00
Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml 16 14 $0.00
E1390 Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate 16 13 $0.00